4//SEC Filing
MEI Pharma, Inc. 4
Accession 0001209191-16-134681
$LITSCIK 0001262104operating
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 5:29 PM ET
Size
5.8 KB
Accession
0001209191-16-134681
Insider Transaction Report
Form 4
MEI Pharma, Inc.MEIP
Mass Robert D.
Chief Medical Officer
Transactions
- Award
Option to purchase shares of common stock
2016-07-29+135,000→ 420,556 totalExercise: $1.36Exp: 2026-07-29→ Common Stock par value $0.00000002 (135,000 underlying)
Footnotes (2)
- [F1]One-quarter of the options will vest on July 29, 2017; the remaining three-quarters of the options will vest in equal monthly installments over the following thirty-six months.
- [F2]The total number of derivative securities reported in Column 9 includes previously awarded options, which were subject to the effect of a 1 for 6 reverse stock split, which was effective on December 18, 2012.
Documents
Issuer
MEI Pharma, Inc.
CIK 0001262104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001262104
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 5:29 PM ET
- Size
- 5.8 KB